Profound Medical (PROF) Current Deferred Revenue (2018 - 2026)
Profound Medical's (PROF) quarterly Current Deferred Revenue came in at $464000.0 in Q1 2026, down 27.04% year-on-year from $636000.0 in Q1 2025, and up 4.27% quarter-over-quarter from $445000.0 in Q4 2025.
Profound Medical (PROF) Current Deferred Revenue (2018 - 2026) Analysis & Trends
Profound Medical's Current Deferred Revenue history runs 9 years deep, the most recent figure standing at $464000.0 for Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 27.04% year-over-year to $464000.0 in Q1 2026; TTM through Mar 2026 was $464000.0, a 27.04% decrease from a year earlier, with the FY2025 full-year figure at $445000.0, up 6.21% from the prior year.
- Current Deferred Revenue advanced to $464000.0 in Q1 2026 per PROF's latest filing, from $445000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $721000.0 in Q4 2023 and bottomed at $419000.0 in Q4 2024.
- The 5-year median for Current Deferred Revenue is $467500.0 (2022), against an average of $535500.0.
- Across the five-year window, Current Deferred Revenue surged 53.08% in 2023 and plunged 41.89% in 2024, its largest moves.
- Year by year, Current Deferred Revenue stood at $471000.0 in 2022, then soared by 53.08% to $721000.0 in 2023, then sank by 41.89% to $419000.0 in 2024, then increased by 6.21% to $445000.0 in 2025, then gained by 4.27% to $464000.0 in 2026.
- Per Business Quant, the three latest PROF Current Deferred Revenue figures stand at $464000.0 (Q1 2026), $445000.0 (Q4 2025), and $434000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Profound Medical | 248.64 Mn | 198.34 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 464,000.00 |
| Dec 31, 2025 | 445,000.00 |
| Sep 30, 2025 | 434,000.00 |
| Jun 30, 2025 | 694,000.00 |
| Mar 31, 2025 | 636,000.00 |
| Dec 31, 2024 | 419,000.00 |
| Dec 31, 2023 | 721,000.00 |
| Dec 31, 2022 | 471,000.00 |
| Dec 31, 2021 | 477,000.00 |
| Dec 31, 2020 | 358,000.00 |
| Dec 31, 2019 | 496,161.42 |
| Jan 1, 2019 | 229,000.00 |
| Dec 31, 2018 | 236,800.13 |